These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7673235)

  • 1. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound.
    Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Moss D; Thomson TA; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E
    J Biol Chem; 1995 Sep; 270(38):22467-72. PubMed ID: 7673235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide.
    Bruneau JM; Yea CM; Spinella-Jaegle S; Fudali C; Woodward K; Robson PA; Sautès C; Westwood R; Kuo EA; Williamson RA; Ruuth E
    Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):299-303. PubMed ID: 9820804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.
    Knecht W; Löffler M
    Biochem Pharmacol; 1998 Nov; 56(9):1259-64. PubMed ID: 9802339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria.
    Jöckel J; Wendt B; Löffler M
    Biochem Pharmacol; 1998 Oct; 56(8):1053-60. PubMed ID: 9776318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
    Baldwin J; Farajallah AM; Malmquist NA; Rathod PK; Phillips MA
    J Biol Chem; 2002 Nov; 277(44):41827-34. PubMed ID: 12189151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.
    McLean JE; Neidhardt EA; Grossman TH; Hedstrom L
    Biochemistry; 2001 Feb; 40(7):2194-200. PubMed ID: 11329288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme.
    Knecht W; Bergjohann U; Gonski S; Kirschbaum B; Löffler M
    Eur J Biochem; 1996 Aug; 240(1):292-301. PubMed ID: 8925840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.
    Knecht W; Henseling J; Löffler M
    Chem Biol Interact; 2000 Jan; 124(1):61-76. PubMed ID: 10658902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
    Greene S; Watanabe K; Braatz-Trulson J; Lou L
    Biochem Pharmacol; 1995 Sep; 50(6):861-7. PubMed ID: 7575649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects?
    Ullrich A; Knecht W; Fries M; Löffler M
    Eur J Biochem; 2001 Mar; 268(6):1861-8. PubMed ID: 11248707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
    Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain.
    Hansen M; Le Nours J; Johansson E; Antal T; Ullrich A; Löffler M; Larsen S
    Protein Sci; 2004 Apr; 13(4):1031-42. PubMed ID: 15044733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents.
    Liu S; Neidhardt EA; Grossman TH; Ocain T; Clardy J
    Structure; 2000 Jan; 8(1):25-33. PubMed ID: 10673429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.
    Xu X; Blinder L; Shen J; Gong H; Finnegan A; Williams JW; Chong AS
    J Immunol; 1997 Jul; 159(1):167-74. PubMed ID: 9200452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine.
    Thomson TA; Spinella-Jaegle S; Francesconi E; Meakin C; Millet S; Flao KL; Hidden H; Ruuth E
    Scand J Immunol; 2002 Jul; 56(1):35-42. PubMed ID: 12100469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression.
    Chong AS; Huang W; Liu W; Luo J; Shen J; Xu W; Ma L; Blinder L; Xiao F; Xu X; Clardy C; Foster P; Williams JA
    Transplantation; 1999 Jul; 68(1):100-9. PubMed ID: 10428276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.
    Davis JP; Cain GA; Pitts WJ; Magolda RL; Copeland RA
    Biochemistry; 1996 Jan; 35(4):1270-3. PubMed ID: 8573583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
    Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
    Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase.
    Malmquist NA; Gujjar R; Rathod PK; Phillips MA
    Biochemistry; 2008 Feb; 47(8):2466-75. PubMed ID: 18225919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms.
    Elder RT; Xu X; Williams JW; Gong H; Finnegan A; Chong AS
    J Immunol; 1997 Jul; 159(1):22-7. PubMed ID: 9200434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.